Study population and baseline characteristics
According to the prespecified criteria, 3,274 patient records from the hybrid DSA operating room were identified, and 1,936 (59.1%) met the inclusion criteria and entered model development and validation (Figure 1). The enrolled patients had an age of (66.82 ± 11.94) years; males accounted for 61.16%; BMI was (24.73 ± 3.89) kg/m2; diabetes mellitus accounted for 23.45%. The Charlson comorbidity index was 3 [2,5], the Braden score was 17 [16,19], and preoperative albumin was (39.18 ± 4.41) g/L, indicating a relatively high comorbidity burden and a certain risk of pressure injury (Table 1). Procedures upon entry were mainly neurovascular and cardiovascular; the supine position accounted for 69.78%; general anesthesia accounted for 77.89%. The median operative duration was 174 min, the median fluoroscopy duration was 37 min, 76.81% of cases had an intraoperative non-turnable status, the lowest MAP was (63.72 ± 8.96) mmHg, and 45.99% used vasoactive agents, suggesting that patients generally had prolonged positional exposure with a certain risk of circulatory instability (Table 2). Regarding nursing and devices, the usage rate of gel pressure-relief padding was 40.24%; the completion rate of protection at four key pressure points was 72.77%; head supported in a neutral position was 78.68%; and the completeness of intraoperative position check documentation was 86.39%. Arterial access was predominantly femoral (62.32%); the median sheath size was 6 Fr, and the median dwell time was 142 min; puncture sites were mostly secured with compression bandage or vascular closure device (Table 3).
Outcome incidence and data quality
From intraoperative through 72 h postoperatively, the incidence of the composite outcome of position-related complications was 10.23%. Among the components, pressure injury (4.08%) and position-related respiratory/hemodynamic instability events (5.01%) were most common; peripheral nerve injury was 1.60%, puncture-site complications were 2.74%, and joint or musculoskeletal injury was 0.88% (Table 4). Among the 1,936 included cases, the overall missingness for key predictors was low (maximum 3.25%), and there was no missingness for the outcome variables. Cases with >30% missingness across prespecified key predictor variables had been excluded during screening. After handling the remaining predictor missingness using multiple imputation by chained equations (m = 10), the number of observations available for modeling remained 1,936 in the imputed datasets (Table 5). Consistency re-extraction for key variables showed good consistency for categorical variables (Cohen κ ≥ 0.86 for all) and for continuous variables (ICC ≥ 0.89 for all), satisfying the consistency thresholds (Table 6).
Development of the predictive model
Univariable Logistic regression showed that increased age, higher Charlson comorbidity index, lower Braden score, longer operative duration, lower lowest MAP, and lower core temperature were all associated with an increased risk of position-related complications; the prone position, longer cumulative time with MAP < 65 mmHg, and larger sheath size further indicated elevated risk. Among nursing process factors, completing key pressure-point protection and intraoperative position check documentation was associated with protective effects, whereas femoral-artery access was associated with a higher risk. Candidate variables were screened per the prespecified rule (P < 0.20) to enter LASSO modeling (Figure 2A). At λ_min, a total of 12 variables with nonzero coefficients were selected, including seven baseline risk factors (age, higher Charlson index, lower Braden score, longer operative duration, prone position, longer cumulative time with MAP < 65 mmHg, and lower lowest core temperature) and 5 nursing process factors (femoral-artery access, larger sheath size, longer sheath dwell time, completion of key pressure-point protection, and completeness of intraoperative position check documentation) to construct the subsequent multivariable model (Figure 2B). The final multivariable Logistic regression model included 12 variables (all P < 0.05). The seven baseline risk factors included increased age, higher Charlson comorbidity index, lower Braden score, longer operative duration, prone position, hypotension exposure (longer cumulative time with MAP<65 mmHg), and lower core temperature (OR = 1.06–1.64); the 5 nursing process factors included femoral-artery access, larger sheath size, and longer sheath dwell time (OR = 1.08–1.34, increased risk), and completion of key pressure-point protection and intraoperative position check documentation being complete (OR = 0.68–0.71, protective factors) (Table 7).
Presentation of the predictive tool and internal validation
Based on the final multivariable model, a nomogram was constructed using Sullivan linear scaling, converting seven baseline risk factors and five nursing process factors into a total point score and mapping it to the predicted probability of position-related complications; stratification by <5%, 5–14.9%, and ≥15% was used for risk assessment and nursing decision support preoperatively and after positioning, with protective items among the nursing process factors reflecting their modifiable nature (Figure 3A). The AUC was estimated using the DeLong method; the apparent AUC of the baseline risk model was 0.74 and was 0.72 after bootstrap correction; the apparent AUC of the updated full model was 0.79 and was 0.77 after correction, indicating better discrimination than the model containing only baseline risk (Figure 3B). The calibration curves overall approximated the 45° ideal line (Figure 3C). After bootstrap optimism correction, the updated full model had a calibration slope of 0.947 and an intercept of +0.004, closer to the ideal values (slope 1, intercept 0) than the baseline risk model's values of 0.903 and +0.006, indicating better calibration. The overall error of both models was low, with a corrected Brier score of 0.085 for the full model, lower than 0.089 for the baseline risk model; for reference, the Brier score of the null model based on the observed event incidence of 10.23% was 0.092 (Table 8).
Clinical applicability and risk stratification performance
Decision curve analysis showed that within a threshold probability range of 5%–20%, both models had higher net benefit than the Treat-All and Treat-None strategies, and the updated full model consistently exceeded the baseline risk model, suggesting that incorporating nursing process variables provides additional clinical net benefit (Figure 4). Under the predefined thresholds, the updated full model stratified patients into low-, intermediate-, and high-risk groups, with observed incidences of 1.29%, 9.28%, and 35.07%, respectively. At the 5% threshold, sensitivity, specificity, positive predictive value, and negative predictive value of the updated full model were 95.45%, 39.76%, 15.30%, and 98.71%, respectively; at the 15% threshold, the corresponding values were 51.01%, 89.24%, 35.07%, and 94.11%, respectively (Table 9). Under the strict outcome and alternative hypotension threshold scenarios, the AUCs of both models remained overall at 0.71–0.81, with small changes in the Brier score and calibration intercept, and the calibration slope remaining close to 1. The updated full model maintained slightly better discrimination and calibration than the baseline risk model in both sensitivity analyses, suggesting some robustness in the model’s performance (Table 10).

Figure 1: Case screening flowchart. The study period was January 1, 2021, to December 31, 2024, with follow‑up through 72 h postoperatively. Percentages were calculated using the number of identified surgical records as the denominator. The analysis cohort included one eligible index procedure per patient; m = 10 indicates the number of imputed datasets. Please click here to view a larger version of this figure.

Figure 2: Predictor screening and selection process. (A) Univariate logistic regression results are shown as odds ratios with 95% confidence intervals and two‑sided P values; continuous predictors were modeled using prespecified clinically meaningful increments, and categorical predictors were used with predefined reference categories. Analyses were fitted across m = 10 imputed datasets and pooled using Rubin’s rules. (B) LASSO logistic regression used standardized predictors; λ_min was selected by 10‑fold cross‑validation repeated 1,000x. Abbreviations: ORs = odds ratios; CIs = confidence intervals. Please click here to view a larger version of this figure.

Figure 3: Development and validation of a nursing Predictive assessment tool. (A) The nomogram was derived from the final multivariable model using Sullivan’s point‑based scaling; total points were mapped to predicted probability and prespecified risk strata (low <5%, intermediate 5–14.9%, high ≥15%). (B) ROC curves are shown for baseline‑risk and updated models, with apparent and bootstrap-corrected AUCs; AUC 95% CIs were estimated using the DeLong method. (C) Calibration curves display observed versus predicted risks by deciles, with both apparent and bootstrap‑corrected curves and the 45° ideal line; calibration intercept and slope are annotated. Please click here to view a larger version of this figure.

Figure 4: Decision curve analysis (apparent). Net benefit was calculated across threshold probabilities of 2%–25% and compared between the baseline‑risk model, updated model, Treat‑All, and Treat‑None strategies. “Apparent” indicates estimates from the development cohort without optimism correction. Higher net benefit indicates greater clinical utility at a given threshold. Please click here to view a larger version of this figure.
| Variable name | Summary statistics | Valid observations n |
| Age | 66.82 ± 11.94 | 1936 |
| Sex | Male 1184 (61.16%); Female 752 (38.84%) | 1936 |
| BMI (kg/m²) | 24.73 ± 3.89 | 1912 |
| Diabetes mellitus | 454 (23.45%) | 1936 |
| Peripheral neuropathy | 207 (10.69%) | 1936 |
| Peripheral arterial disease | 251 (12.96%) | 1936 |
| Chronic kidney disease ≥stage 3 | 238 (12.29%) | 1936 |
| Congestive heart failure | 211 (10.90%) | 1936 |
| Smoking status | Never 926 (49.02%); Former 503 (26.63%); Current 460 (24.35%) | 1889 |
| Preoperative albumin (g/L) | 39.18 ± 4.41 | 1873 |
| Preoperative hemoglobin (g/L) | 128.61 ± 16.97 | 1897 |
| Charlson comorbidity index | 3 [2,5] | 1936 |
| Preoperative Braden score | 17 [16,19] | 1936 |
Table 1: Patient baseline characteristics (patient-related factors). Continuous variables are presented as mean ± SD or median [IQR], depending on distribution; categorical variables are presented as n (%). Percentages were calculated using the number of available observations for each variable as the denominator. BMI, body mass index. Please click here to download this Table.
| Variable name | Summary statistics | Valid observations n |
| Procedure category | Neurovascular 789 (40.75%); Cardiovascular 512 (26.45%); Peripheral vascular 473 (24.43%); Hybrid open abdominal or thoracic plus interventional 162 (8.37%) | 1936 |
| Anesthesia type | General anesthesia 1508 (77.89%); Sedation 428 (22.11%) | 1936 |
| Position type | Supine 1351 (69.78%); Prone 341 (17.61%); Lateral 244 (12.60%) | 1936 |
| Head–neck rotation angle categories | ≤30° 1182 (61.85%); 31–60° 546 (28.57%); >60° 183 (9.58%) | 1911 |
| Upper-limb abduction angle categories | ≤90° 1469 (76.75%); >90° 445 (23.25%) | 1914 |
| Lower-limb abduction or flexion >45° | Yes 611 (31.63%); No 1321 (68.37%) | 1932 |
| Operative duration (min) | 174 [113, 243] | 1936 |
| Fluoroscopy duration (min) | 37 [21, 69] | 1927 |
| Intraoperative non-turnable status | Yes 1487 (76.81%); No 449 (23.19%) | 1936 |
| Estimated blood loss (mL) | 130 [70, 310] | 1908 |
| Lowest mean arterial pressure (mmHg) | 63.72 ± 8.96 | 1930 |
| Cumulative time with mean arterial pressure <65 mmHg (min) | 21 [9, 44] | 1930 |
| Lowest core temperature (°C) | 35.78 ± 0.62 | 1899 |
| Use of vasoactive agents | Used 889 (45.99%); Not used 1044 (54.01%) | 1933 |
| Maximum norepinephrine equivalent (µg/kg/min) | 0.06 [0.03, 0.11] | 889 |
Table 2: Surgical and anesthesia characteristics. Continuous variables are presented as mean ± SD or median [IQR]; categorical variables as n (%), with percentages based on available observations. MAP, mean arterial pressure. The maximum norepinephrine equivalent was summarized only among cases receiving vasoactive agents. Please click here to download this Table.
| Variable name | Summary statistics | Valid observations n |
| Operating-table padding type | Standard padding 1157 (59.76%); Gel pressure-relief padding 779 (40.24%) | 1936 |
| Completion of key pressure-point protection | All four sites completed 1398 (72.77%); Not all completed 523 (27.23%) | 1921 |
| Upper-limb securement method | Padded arm boards 1544 (80.80%); Other 367 (19.20%) | 1911 |
| Head supported in neutral position | Yes 1517 (78.68%); No 411 (21.32%) | 1928 |
| Puncture-site category | Radial artery 556 (29.46%); Brachial artery 131 (6.94%); Femoral artery 1176 (62.32%); Carotid artery 24 (1.27%) | 1887 |
| Sheath size (Fr) | 6 [5, 7] | 1882 |
| Sheath dwell time (min) | 142 [87, 229] | 1884 |
| Puncture-site securement or closure method | Compression bandage 1022 (54.54%); Suture closure device 286 (15.26%); Vascular closure device 566 (30.20%) | 1874 |
| Completeness of intraoperative position check documentation | Complete 1657 (86.39%); Incomplete 261 (13.61%) | 1918 |
Table 3: Nursing and device characteristics. Categorical variables are presented as n (%) and continuous variables as mean ± SD or median [IQR], with percentages based on available observations. “Key pressure‑point protection completed” indicates protection at occiput, scapula, sacrum/coccyx, and heels. Sheath‑related variables and access‑site fixation/closure method were summarized only among cases with documented arterial access. Please click here to download this Table.
| Outcome category | Number of events n | Incidence % | Brief basis for determination |
| Composite outcome (≥1 position-related complication) | 198 | 10.23 | Any component event present counted toward the composite outcome |
| Pressure injury (stage 2 or higher or deep tissue injury) | 79 | 4.08 | New within 72 h; staging confirmed by nursing records and skin assessment forms |
| Peripheral nerve injury | 31 | 1.6 | Symptoms persisted ≥24 h; anatomic distribution consistent with contact/traction at the position; documented specialist assessment |
| Joint or musculoskeletal injury | 17 | 0.88 | Positive physical examination findings and position-related; or imaging evidence supporting traction/compression injury |
| Position-related respiratory or hemodynamic instability events | 97 | 5.01 | Position-induced need for repositioning, vasopressor escalation, compression, or brief pause of the procedure |
| Puncture-site complications with aggravation related to positional constraints | 53 | 2.74 | Hematoma diameter ≥5 cm on the puncture side or oozing requiring additional compression fixation; documented as related to positional constraints |
Table 4: Incidence and composition of position-related complications (intraoperative to 72 h postoperatively). The composite outcome was counted once per procedure; component events were not mutually exclusive. Rates were calculated as n/N using the total included cohort as the denominator. “Access‑site complication aggravated by positioning restriction” was defined as hematoma ≥5 cm or bleeding requiring additional compression fixation. Please click here to download this Table.
| Variable name | Number missing n | Missingness % |
| Body mass index | 24 | 1.24 |
| Smoking status | 47 | 2.43 |
| Preoperative albumin | 63 | 3.25 |
| Preoperative hemoglobin | 39 | 2.01 |
| Head–neck rotation angle categories | 25 | 1.29 |
| Upper-limb abduction angle categories | 22 | 1.14 |
| Lower-limb abduction or flexion >45° | 4 | 0.21 |
| Fluoroscopy duration | 9 | 0.47 |
| Estimated blood loss | 28 | 1.45 |
| Lowest mean arterial pressure | 6 | 0.31 |
| Cumulative time with mean arterial pressure <65 mmHg | 6 | 0.31 |
| Lowest core temperature | 37 | 1.91 |
| Use of vasoactive agents | 3 | 0.16 |
| Completion of key pressure-point protection | 15 | 0.77 |
| Upper-limb securement method | 25 | 1.29 |
| Head supported in a neutral position | 8 | 0.41 |
| Puncture-site category | 49 | 2.53 |
| Sheath size | 54 | 2.79 |
| Sheath dwell time | 52 | 2.69 |
| Puncture-site securement or closure method | 62 | 3.2 |
| Completeness of intraoperative position check documentation | 18 | 0.93 |
Table 5: Missingness of key variables and sample size after imputation. Missingness is reported as n (%) using N = 1,936 as the denominator for each variable. Multiple imputation by chained equations was performed with m=10 datasets; the outcome was not imputed, and inferential analyses were pooled using Rubin’s rules. Maximum norepinephrine equivalent was coded as 0 µg/kg/min for patients not receiving vasoactive agents. Please click here to download this Table.
| Variable name | Repeated extraction sample size n | Cohen κ | ICC |
| Position type (supine/prone/lateral) | 50 | 0.93 | — |
| Head–neck rotation angle categories (≤30°/31–60°/>60°) | 49 | 0.88 | — |
| Upper-limb abduction angle categories (≤90°/>90°) | 48 | 0.91 | — |
| Lower-limb abduction or flexion >45° | 50 | 0.9 | — |
| Intraoperative non-turnable status | 50 | 0.95 | — |
| Anesthesia type (general anesthesia/sedation) | 50 | 0.96 | — |
| Operating-table padding type (standard/gel) | 50 | 0.89 | — |
| Completion of key pressure-point protection (all four completed/not all completed) | 47 | 0.87 | — |
| Upper-limb securement method (padded arm boards/other) | 48 | 0.92 | — |
| Head supported in a neutral position (yes/no) | 49 | 0.94 | — |
| Puncture-site category (radial/brachial/femoral/carotid) | 46 | 0.9 | — |
| Puncture-site securement or closure method (compression bandage/suture closure/vascular closure device) | 46 | 0.86 | — |
| Completeness of intraoperative position check documentation (complete/incomplete) | 50 | 0.91 | — |
| Determination of composite outcome (≥1 position-related complication) | 50 | 0.93 | — |
| Occurrence of pressure injury (stage ≥2) | 50 | 0.9 | — |
| Determination of position-related respiratory/hemodynamic instability events | 50 | 0.92 | — |
| Occurrence of peripheral nerve injury | 50 | 0.89 | — |
| Occurrence of joint or musculoskeletal injury | 50 | 0.88 | — |
| Puncture-site complications with aggravation related to positional constraints | 50 | 0.9 | — |
| Operative duration (min) | 50 | — | 0.97 |
| Fluoroscopy duration (min) | 49 | — | 0.94 |
| Estimated blood loss (mL) | 49 | — | 0.91 |
| Cumulative time with mean arterial pressure <65 mmHg (min) | 50 | — | 0.92 |
| Lowest mean arterial pressure (mmHg) | 50 | — | 0.96 |
| Lowest core temperature (°C) | 50 | — | 0.93 |
| Sheath size (Fr) | 46 | — | 0.98 |
| Sheath dwell time (min) | 46 | — | 0.95 |
| Preoperative Braden score (points) | 50 | — | 0.9 |
| Charlson comorbidity index (points) | 50 | — | 0.91 |
| Maximum norepinephrine equivalent (µg/kg/min) | 23 | — | 0.89 |
Table 6: Consistency of data extraction. Duplicate abstraction was performed in an initial sample (up to 50 procedures). Cohen’s κ was used for categorical variables and ICC for continuous variables (two‑way random effects, absolute agreement); κ≥0.80 or ICC≥0.85 indicated acceptable reliability. “—” denotes not applicable. Please click here to download this Table.
| Variable name | β | SE | OR (95% CI) | P value |
| Age (per 10-year increase) | 0.13 | 0.06 | 1.14 (1.02, 1.29) | 0.029 |
| Charlson index (per 1-point increase) | 0.1 | 0.03 | 1.10 (1.04, 1.18) | 0.003 |
| Braden score (per 1-point decrease) | 0.06 | 0.03 | 1.06 (1.01, 1.12) | 0.027 |
| Operative duration (per 60 min increase) | 0.17 | 0.05 | 1.18 (1.08, 1.30) | <0.001 |
| Position: prone vs supine | 0.49 | 0.17 | 1.64 (1.18, 2.26) | 0.003 |
| Cumulative time with MAP<65 mmHg (per 10 min increase) | 0.07 | 0.03 | 1.07 (1.02, 1.13) | 0.01 |
| Lowest core temperature (per 0.5 °C decrease) | 0.11 | 0.05 | 1.12 (1.01, 1.25) | 0.037 |
| Puncture site: femoral artery vs radial artery | 0.29 | 0.14 | 1.34 (1.01, 1.78) | 0.043 |
| Sheath size (per 1 Fr increase) | 0.09 | 0.04 | 1.09 (1.02, 1.17) | 0.014 |
| Sheath dwell time (per 60 min increase) | 0.08 | 0.03 | 1.08 (1.02, 1.15) | 0.012 |
| Pressure-point protection: completed vs not all completed | -0.39 | 0.15 | 0.68 (0.50, 0.91) | 0.012 |
| Intraoperative position check documentation: complete vs incomplete | -0.34 | 0.17 | 0.71 (0.51, 0.98) | 0.04 |
| Intercept | -2.26 | 0.38 | 0.10 (0.05, 0.22) | — |
Table 7: Regression coefficients and odds ratios of the final multivariable logistic regression model. The final model was refit as an unpenalized multivariable logistic regression using the predictors selected at λ_min. Results are reported as β, SE, OR (95% CI), and two‑sided P values; the intercept is provided without a P value. Coefficients are apparent (development‑cohort) estimates. Please click here to download this Table.
| Model | Estimate type | AUC (95% CI) | Brier score | Calibration intercept | Calibration slope |
| Null model | Reference | 0.5 | 0.092 | — | — |
| Baseline risk model | Apparent | 0.74 (0.70–0.78) | 0.087 | 0.004 | 0.961 |
| Baseline risk model | Bootstrap-corrected | 0.72 (0.68–0.76) | 0.089 | 0.006 | 0.903 |
| Updated full model | Apparent | 0.79 (0.76–0.83) | 0.083 | 0.003 | 0.983 |
| Updated full model | Bootstrap-corrected | 0.77 (0.73–0.81) | 0.085 | 0.004 | 0.947 |
Table 8: Model calibration and overall error metrics. Brier score, calibration intercept, and calibration slope are reported for apparent and bootstrap optimism‑corrected estimates. Lower Brier scores indicate better overall accuracy; calibration intercept 0 and slope 1 indicate ideal calibration. Please click here to download this Table.
| Risk tier | Number of cases within tier n | Obser-
ved incidence % | Se
@5% (baseline) % | Se
@5% (full) % | Sp
@5% (baseline) % | Sp
@5% (full) % | PPV
@5% (baseline) % | PPV
@5% (full) % | NPV
@5% (baseline) % | NPV
@5% (full) % | Se
@15% (baseline) % | Se
@15% (full) % | Sp
@15% (baseline) % | Sp@
15% (full) % | PPV
@15% (baseline) % | PPV
@15% (full) % | NPV
@15% (baseline) % | NPV
@15% (full) % |
| Low risk <5% | 700 | 1.29 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Intermediate risk 5–14.9% | 948 | 9.28 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| High risk ≥15% | 288 | 35.07 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Overall (threshold=5%) | — | — | 87.9 | 95.45 | 41.1 | 39.76 | 14.54 | 15.3 | 96.75 | 98.71 | — | — | — | — | — | — | — | — |
| Overall (threshold=15%) | — | — | — | — | — | — | — | — | — | — | 41.92 | 51.01 | 89.96 | 89.24 | 32.24 | 35.07 | 93.15 | 94.11 |
Table 9: Observed incidence after predefined risk stratification and classification performance at thresholds. Risk groups were defined by the updated model's predicted probability: low (<5%), intermediate (5–14.9%), and high (≥15%); observed event rates were calculated as x/n within each group. Sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) were computed at prespecified thresholds of 5% and 15% for both the baseline‑risk and updated models. No additional hypothesis testing was performed. Please click here to download this Table.
| Scenario setting | Model version | AUC | Brier | Calibration intercept | Calibration slope | Optimism-corrected or not |
| Strict outcome (pressure injury limited to stage 3 or higher) | Baseline risk model (apparent) | 0.76 | 0.079 | 0.004 | 0.958 | No |
| Baseline risk model (bootstrap corrected) | 0.74 | 0.081 | 0.006 | 0.904 | Yes |
| Updated full model (apparent) | 0.81 | 0.074 | 0.003 | 0.981 | No |
| Updated full model (bootstrap corrected) | 0.79 | 0.076 | 0.004 | 0.944 | Yes |
| Alternative hypotension threshold (cumulative time with MAP<60 mmHg replacing <65 mmHg) | Baseline risk model (apparent) | 0.73 | 0.091 | 0.005 | 0.941 | No |
| Baseline risk model (bootstrap corrected) | 0.71 | 0.094 | 0.007 | 0.887 | Yes |
| Updated full model (apparent) | 0.78 | 0.086 | 0.004 | 0.972 | No |
| Updated full model (bootstrap corrected) | 0.76 | 0.088 | 0.006 | 0.935 | Yes |
Table 10: Sensitivity analyses. Model development and internal validation procedures were repeated under two prespecified scenarios: (1) strict outcome definition (pressure injury stage ≥ 3) and (2) alternative hypotension exposure (cumulative time MAP < 60 mmHg, replacing MAP < 65 mmHg). Within each scenario, the baseline risk model and the updated full model are presented separately. AUC values are point estimates; Brier score, calibration intercept, and calibration slope are reported as apparent and bootstrap optimism-corrected estimates. “Apparent” indicates estimates obtained in the development cohort, whereas “bootstrap optimism-corrected” indicates estimates after bootstrap correction for optimism. Please click here to download this Table.
Supplemental Table S1: TRIPOD checklist for reporting of multivariable prediction model development and internal validation. The table indicates the location of each TRIPOD item within the manuscript.Please click here to download this file.